A Pilot Study of Shockwave Therapy in HSP

Status Withdrawn

Clinical Trial Summary

This is a pilot study of the efficacy, safety, and tolerability of shockwave therapy for the treatment of spasticity in Hereditary Spastic Paraplegia.

Clinical Trial Description

This is a pilot study investigating the efficacy, safety, and tolerability of Extracorporeal Shockwave Therapy (ESWT) for the treatment of lower-extremity spasticity in the setting of Hereditary Spastic Paraplegia (HSP). 8 participants will be treated with shockwave therapy targeting sites of maximal spasticity in the lower extremities for 3 sessions at a rate of once per week. Participants will fill out baseline questionnaires assessing their overall wellbeing and function prior to treatment session 1, and will complete follow-up questionnaires at visit 2, visit 3, a phone call within 7 days of visit 3, and 8 weeks after initial visit. Total time enrolled in the study will be 8 weeks ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05411627
Study type	Interventional
Source	Spaulding Rehabilitation Hospital
Contact
Status	Withdrawn
Phase	N/A
Start date	January 1, 2023
Completion date	December 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06117020` - Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals	Phase 1
Completed	`NCT05373082` - Identification of Modifying Factors in Hereditary Spastic Paraplegia
Recruiting	`NCT03981276` - Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
Terminated	`NCT02859428` - Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31
Completed	`NCT03104088` - Studying Cognition in SPG4
Recruiting	`NCT05848271` - Natural History Study of Patients With HPDL Mutations
Completed	`NCT02604186` - Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia	Phase 2/Phase 3
Completed	`NCT04912609` - Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)
Recruiting	`NCT03206190` - The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4	N/A
Completed	`NCT03627416` - Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy	N/A
Recruiting	`NCT04875416` - Phenotype, Genotype and Biomarkers 2
Completed	`NCT03961906` - Physiotherapy in Hereditary Spastic Paraplegia	Phase 2
Completed	`NCT05767268` - Assessment of the Psychophysical State During Rehabilitation Treatment With Lokomat
Completed	`NCT02852278` - A Patient Centric Motor Neuron Disease Activities of Daily Living Scale
Completed	`NCT04180098` - Improving Gait Adaptability in Hereditary Spastic Paraplegia	N/A
Completed	`NCT05613114` - Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia	N/A
Completed	`NCT00023075` - Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis	N/A
Recruiting	`NCT04712812` - Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
Recruiting	`NCT05354622` - Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Enrolling by invitation	`NCT02327845` - Phenotype, Genotype & Biomarkers in ALS and Related Disorders